MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 130 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | -66.7% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $3,000 | +50.0% | 1,000 | +100.0% | 0.00% | +100.0% |
| Q4 2016 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $4,000 | +100.0% | 500 | +66.7% | 0.00% | +100.0% |
| Q4 2015 | $2,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 1,560,530 | $17,634,000 | 4.71% |
| B & T Capital Management DBA Alpha Capital Management | 280,113 | $3,165,000 | 2.22% |
| Schonfeld Group Holdings LLC | 10,000 | $113,000 | 1.51% |
| COLUMBIA CAPITAL LLC | 117,702 | $1,331,000 | 1.45% |
| Portolan Capital Management | 607,288 | $6,862,000 | 1.38% |
| Price Capital Management, Inc. | 118,047 | $1,334,000 | 1.18% |
| GARRISON BRADFORD & ASSOCIATES INC | 90,700 | $1,025,000 | 0.93% |
| Opus Point Partners Management, LLC | 72,009 | $814,000 | 0.80% |
| EAM Investors, LLC | 412,233 | $4,658,000 | 0.65% |
| TFS CAPITAL LLC | 476,105 | $5,380,000 | 0.51% |